Company description

ICON plc is a global clinical research organisation headquartered in Dublin, Ireland, supporting pharmaceutical, biotechnology, medical device and government organisations across the drug and device development lifecycle. Founded in 1990, the company has grown from a small five-person team into one of the world’s largest CROs, delivering services from early-phase development through to commercialisation and post-market support.

The company provides outsourced clinical development and healthcare intelligence services designed to accelerate the development of drugs and medical devices. ICON works with organisations ranging from emerging biotechnology companies to large multinational pharmaceutical firms, helping them navigate complex clinical development and regulatory pathways.

ICON operates globally with approximately 40,000 employees across more than 55 countries and over 100 locations, supporting both regional and large-scale global clinical programmes. Its international footprint enables the company to manage multi-regional trials and provide flexible outsourcing models for sponsors.

The organisation combines clinical research, consulting and technology-enabled solutions, supporting development from early discovery through Phase I-IV trials and commercialisation. ICON focuses on improving patient outcomes by accelerating the development of innovative therapies and medical technologies.

Key products and services

Clinical development services

• Phase I–IV clinical trial management
• Clinical operations and site management
• Patient recruitment and retention strategies
• Decentralised, hybrid and traditional trial models

Early phase and specialised clinical services

• Early clinical development and first-in-human studies
• Trial design and protocol development
• Complex and specialised therapeutic area expertise

Consulting and advisory services

• Asset development consulting
• Regulatory and development strategy
• Scientific and operational advisory services

Laboratory and biometrics services

• Central laboratory testing
• Data management and statistical analysis
• Integrated laboratory and clinical operations

Commercialisation and lifecycle support

• Market access and commercial strategy
• Post-marketing studies
• Real-world evidence and lifecycle management

By combining global clinical research expertise with consulting and commercialisation capabilities, ICON plc positions itself as a strategic partner for life sciences organisations worldwide. Its integrated lifecycle approach, global footprint and therapeutic expertise enable sponsors to accelerate development timelines, reduce risk and bring innovative therapies and medical technologies to market more efficiently.